参考文献/References:
［1］ ZINTER M S,DUBOIS S G,SPICER A,et al.Pediatric cancer type predicts infection rate,need for critical care intervention,and mortality in the pediatric intensive care unit［J］.Intens Care Med,2014,40(10):1536-1544.
［2］ DIAS S,HATTORI K,ZHU Z,et al.Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration［J］.J Clin Invest,2000,106(4):511-521.
［3］ ZHU B,ZHANG J,CHEN J,et al.Molecular biological characteristics of the recruitment of hematopoietic stem cells from bone marrow niche in chronic myeloid leukemia［J］.Int J Clin Exp Pathol,2015,8(10):12595-12607.
［4］ REDONDO-MUNOZ J,ESCOBAR-DAZ E,SAMANIEGO R,et al.MMP-9 in B-cell chronic lymphocytic leukemia is up-regulated by α4β1 integrin or CXCR4 engagement via distinct signaling pathways,localizes to podosomes,and is involved in cell invasion and migration［J］.Blood,2006,108(9):3143-3151.
［5］ KOTULA-BALAK M,MILON A,PAWLICKI P,et al.Insights into the role of estrogen-related receptors α,β and γ in tumor Leydig cells［J］.Tissue Cell,2018,52:78-91.
［6］ WANG X,CHEN X,SUN L,et al.MicroRNA-34a inhibits cell growth and migration in human glioma cells via MMP-9［J］.Mol Med Rep,2019,20(1):57-64.
［7］ SCHNEIDER P,COSTA O,LEGRAND E,et al.In vitro secretion of matrix metalloprotease 9 is a prognostic marker in childhood acute lymphoblastic leukemia［J］.Leuk Res,2010,34(1):24-31.
［8］ ERLER J T,BENNEWITH K L,COX T R,et al.Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche［J］.Cancer Cell,2009,15(1):35-44.
［9］ PAPADANTONAKIS N,MATSUURA S,RAVID K.Megakaryocyte pathology and bone marrow fibrosis:the lysyl oxidase connection［J］.Blood,2012,120(9):1774-1781.
［10］ TADMOR T,BEJAR J,ATTIAS D,et al.The expression of lysyl-oxidase gene family members in myeloproliferative neoplasms［J］.Am J Hematol,2013,88(5):355-358.
［11］ OHANIAN M,FADERL S,RAVANDI F,et al.Is acute myeloid leukemia a liquid tumor［J］.Int J Cancer,2013,133(3):534-543.
［12］ KUNADT D,KRAMER M,DILL C,et al.Lysyl oxidase expression is associated with inferior outcome and extramedullary disease of acute myeloid leukemia［J］.Biomark Res,2020,8:20.
［13］ OSUMI T,AWAZU M,FUJIMURA E,et al.Leukemia kidney infiltration can cause secondary polycythemia by activating hypoxia-inducible factor (HIF) pathway［J］.Eur J Pediatr,2013,172:829-832.
［14］ STEINER O,COISNE C,CECCHELLI R,et al.Differential roles for endothelial ICAM-1,ICAM-2,and VCAM-1 in shear-resistant T cell arrest,polarization,and directed crawling on blood-brain barrier endothelium［J］.J Immunol,2010,185(8):4846-4855.
［15］ SI M Y,FAN Z C,LI Y Z,et al.The prognostic significance of serum and cerebrospinal fluid MMP-9,CCL2 and sVCAM-1 in leukemia CNS metastasis［J］.J Neurooncol,2015,122:229-244.
［16］ STAMOULI M,GKIRKAS K,ANTONIADES A,et al.Isolated extramedullary leukemic involvement of the heart presenting as fulminant heart failure［J］.Ann Hematol,2019,98(7):1775-1776.
［17］ BARTONICEK N,MAAG J L V,DINGER M E.Long noncoding RNAs in cancer:mechanisms of action and technological advancements［J］.Mol Cancer,2016,15:43.
［18］ CUADROS M,ANDRADES ,COIRA I F,et al.Expression of the long non-coding RNA TCL6 is associated with clinical outcome in pediatric B-cell acute lymphoblastic leukemia［J］.Blood Cancer J,2019,9:93.
［19］ FERNANDO T R,RODRIGUEZ-MALAVE N I,WATERS E V,et al.LncRNA expression discriminates karyotype and predicts survival in B-lymphoblastic leukemiaLncRNA expression in B-lymphoblastic leukemia［J］.Mol Cancer Res,2015,13(5):839-851.
［20］ JAMES A R,SCHROEDER M P,NEUMANN M,et al.Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemia［J］.J Hematol Oncol,2019,12:8.
［21］ INFANTE E,HEASMAN S J,RIDLEY A J.Statins inhibit T-acute lymphoblastic leukemia cell adhesion and migration through Rap1b［J］.J Leukoc Biol,2011,89(4):577-586.
［22］ XIA J,WANG M,ZHU Y,et al.Differential mRNA and long noncoding RNA expression profiles in pediatric B-cell acute lymphoblastic leukemia patients［J］.BMC Pediatr,2022,22:10.
［23］ XIU B,ZHANG W,HUANG B,et al.Genetic inhibition of vascular endothelial growth factor receptor-1 significantly inhibits the migration and proliferation of leukemia cells and increases their sensitivity to chemotherapy［J］.Oncol Rep,2013,29(5):2030-2038.
［24］ LIN C,CHEN D,XIAO T,et al.DNA methylation-mediated silencing of microRNA-204 enhances T cell acute lymphoblastic leukemia by up-regulating MMP-2 and MMP-9 via NF-κB［J］.J Cell Mol Med,2021,25(5):2365-2376.
［25］ HSU M T,COCA-PRADOS M.Electron microscopic evidence for the circular form of RNA in the cytoplasm of eukaryotic cells［J］.Nature,1979,280(5720):339-340.
［26］ HIRSCH S,BLTTE T J,GRASEDIECK S,et al.Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia［J］.Haematologica,2017,102(12):2039-2047.
［27］ LV C,SUN L,GUO Z,et al.Circular RNA regulatory network reveals cell-cell crosstalk in acute myeloid leukemia extramedullary infiltration［J］.J Transl Med,2018,16:361.
［28］ LIN L,WANG Y,BIAN S,et al.A circular RNA derived from PLXNB2 as a valuable predictor of the prognosis of patients with acute myeloid leukaemia［J］.J Transl Med,2021,19:123.
［29］ GAFFO E,BOLDRIN E,DAL MOLIN A,et al.Circular RNA differential expression in blood cell populations and exploration of circRNA deregulation in pediatric acute lymphoblastic leukemia［J］.Sci Rep,2019,9:14670.
［30］ LING Z,FANG Z G,WU J Y,et al.The depletion of circ-PRKDC enhances autophagy and apoptosis in T-cell acute lymphoblastic leukemia via microRNA-653-5p/Reelin mediation of the PI3K/AKT/mTOR signaling pathway［J］.Kaohsiung J Med Sci,2021,37(5):392-401.
［31］ EGYED B,KUTSZEGI N,SGI J C,et al.MicroRNA-181a as novel liquid biopsy marker of central nervous system involvement in pediatric acute lymphoblastic leukemia［J］.J Transl Med,2020,18:250.
［32］ JIANG L,MENG W,YU G,et al.MicroRNA-144 targets APP to regulate AML1/ETO+ leukemia cell migration via the p-ERK/c-Myc/MMP-2 pathway［J］.Oncol Lett,2019,18(2):2034-2042.
［33］ SHENG X F,HONG L L,LI H,et al.Long non-coding RNA MALAT1 modulate cell migration,proliferation and apoptosis by sponging microRNA-146a to regulate CXCR4 expression in acute myeloid leukemia［J］.Hematology,2021,26(1):43-52.
［34］ ZHU Q,ZHANG L,LI X,et al.Higher EZH2 expression is associated with extramedullary infiltration in acute myeloid leukemia［J］.Tumour Biol,2016,37(8):11409-11420.
［35］ GRAHAM S R.Treatment of extramedullary myeloid sarcoma with radiotherapy［J］.Cureus,2021,13(6):e15676.
［36］ OERTEL M,ELSAYAD K,HAVERKAMP U,et al.Radiotherapy for extramedullary leukaemic manifestation (Chloroma)［J］.Strahlenther Onkol,2018,194(2):164-173.
［37］ BAKST R L,DABAJA B S,SPECHT L K,et al.Use of radiation in extramedullary leukemia/chloroma:guidelines from the International Lymphoma Radiation Oncology Group［J］.Int J Radiat Oncol Biol Phys,2018,102(2):314-319.
［38］ 中华人民共和国国家卫生健康委员会.儿童急性淋巴细胞白血病诊疗规范（2018版）［EB/OL］.(2018-10-08)［2022-08-26］.http://www.nhc.gov.cn/yzygj/s7653/201810/aef82930c1af4fc5 bf325938e2fcb075.shtml.
NATIONAL HEALTH COMMISSION OF THE PEOPLE′S REPUBLIC OF CHINA.Guidelines for the diagnosis and treatment of children′s acute lymphocytic leukemia (2018 Edition) ［EB/OL］.(2018-10-08)［2022-08-26］.http://www.nhc.gov.cn/yzygj/s7653/201810/aef82930c1af4fc5bf325938e2fcb075.shtml.
［39］ REDDY V K,VAPIWALA N.Secondary malignancy after radiotherapy:not always a secondary concern［J］.Nat Rev Urol,2021,18(9):513-514.
［40］ NGUYEN H T K,TERAO M A,GREEN D M,et al.Testicular involvement of acute lymphoblastic leukemia in children and adolescents:diagnosis,biology,and management［J］.Cancer,2021,127(17):3067-3081.
［41］ DENG M,ZHA J,JIANG Z,et al.Apatinib exhibits anti-leukemia activity in preclinical models of acute lymphoblastic leukemia［J］.J Transl Med,2018,16:47.
［42］ BERTAMINI L,NANNI J,MARCONI G,et al.Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia［J］.BMC Cancer,2018,18:1117.
［43］ JONART L M,EBADI M,BASILE P,et al.Disrupting the leukemia niche in the central nervous system attenuates leukemia chemoresistance［J］.Haematologica,2020,105(8):2130-2140.
［44］ HSIEH Y T,GANG E J,SHISHIDO S N,et al.Effects of the small-molecule inhibitor of integrin α4,TBC3486,on pre-B-ALL cells［J］.Leukemia,2014,28(10):2101-2104.
［45］ JUAREZ J,DELA PENA A,BARAZ R,et al.CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment［J］.Leukemia,2007,21(6):1249-1257.
［46］ HSIEH Y T,GANG E J,GENG H,et al.Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy［J］.Blood,2013,121(10):1814-1818.
［47］ WENG J,LAI P,QIN L,et al.A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia［J］.J Hematol Oncol,2018,11:25.
［48］ LIU Z F,CHEN L Y,WANG J,et al.Successful treatment of acute B lymphoblastic leukemia relapse in the skin and testicle by anti-CD19 CAR-T with IL-6 knocking down:a case report［J］.Biomark Res,2020,8:12.
［49］ HU G H,CHENG Y F,LU A D,et al.Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t (8;21) acute myeloid leukemia in first remission based on MRD-guided treatment［J］.BMC Cancer,2020,20(1):553.
［50］ CHIBA A,TOYA T,MIZUNO H,et al.Chronic myelogenous leukemia presenting with central nervous system infiltration,successfully treated with central nervous system-directed chemotherapy followed by allogeneic stem cell transplantation［J］.Int J Hematol,2018,108(6):640-646.
相似文献/References:
[1]孙玲,潘静夫,赵媛英,等.急非淋白血病完全缓解后巩固治疗的对照研究[J].新乡医学院学报,1995,12(04):341.
[2]赵媛英,贺立山.慢粒合并恶性淋巴瘤1例[J].新乡医学院学报,1996,13(01):025.
[3]孙 毅,王文菊,吴铭辉,等.小儿急性白血病强化疗后并发症的综合防治与护理[J].新乡医学院学报,2000,17(06):474.
[4]马禄重 王淑君 丁现超.老年急性非淋巴细胞性白血病25例分析[J].新乡医学院学报,2000,17(04):290.
[5]潘旅玉.三氧化二砷治疗急性早幼粒细胞白血病的护理[J].新乡医学院学报,2001,18(01):072.
[6]聂常富,冯志博,王建国,等.荧光定量RT—PCR检测急性白血病患者外周血WT1基因的表达[J].新乡医学院学报,2002,19(06):467.
[7]张小毅,韩效林,李晓娟.中西医结合治疗白血病化疗致发热40例[J].新乡医学院学报,2003,20(04):267.
[8]刘迎春,王承云,李树军,等.急性白血病患儿父母应对疾病不确定感的质性研究[J].新乡医学院学报,2021,38(2):137.[doi:10.7683/xxyxyxb.2021.02.008]
LIU Yingchun,WANG Chengyun,LI Shujun,et al.Qualitative study on parents′ coping for illness uncertainty in children with acute leukemia[J].Journal of Xinxiang Medical University,2021,38(1):137.[doi:10.7683/xxyxyxb.2021.02.008]
[9]张 媛,王莉华,郭 燕,等.大黄酸对白血病细胞脂肪量和肥胖相关蛋白表达及细胞增殖和凋亡的影响[J].新乡医学院学报,2021,38(3):220.[doi:10.7683/xxyxyxb.2021.03.004]
ZHANG Yuan,WANG Lihua,GUO Yan,et al.Effect of rhein on expression of fat mass and obesity-associated protein and proliferation and apoptosis of leukemia cells[J].Journal of Xinxiang Medical University,2021,38(1):220.[doi:10.7683/xxyxyxb.2021.03.004]
[10]王会平,郜赵伟,刘 冲,等.腺苷脱氨酶抑制剂红-9-（2-羟基-3-壬烷基）腺嘌呤对白血病细胞凋亡及细胞周期的影响[J].新乡医学院学报,2020,37(10):901.[doi:10.7683/xxyxyxb.2020.10.001]
WANG Huiping,GAO Zhaowei,LIU Chong,et al.Effect of adenosine deaminase inhibitor erythro-9-(2-hydroxy-3-nonyl) adenine on cell apoptosis and cell cycle of leukemia cells[J].Journal of Xinxiang Medical University,2020,37(1):901.[doi:10.7683/xxyxyxb.2020.10.001]